Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basiliximab for Prevention of Acute GVHD in Thalassemia Major HSCT
NCT02342145Phase 4Completed
- Start
- Apr 2015
- Primary completion
- Aug 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of basiliximab in graft-versus-host disease (GVHD). Started Apr 2015; status: completed.
02
Drugs
basiliximab
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT02342145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02342145.